Where untapped medical potential and private equity intersect
Princeton Biopharma Capital Partners, LLC, is a private-equity investment firm focused on investing in commercial-stage healthcare companies.
We provide financial and intellectual capital to commercial-stage healthcare companies with products with growth potential that make a significant impact on patients’ lives.
Latest News
- National Organizations Unite to Prepare Early Childcare Facilities for Rising Incidence of Food AllergiesThe Early Childhood Anaphylaxis Collaborative is rallying the nation’s early childcare centers to improve their preparedness… Read more: National Organizations Unite to Prepare Early Childcare Facilities for Rising Incidence of Food Allergies
- Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®Fidelis Animal Health, Inc. Nov 05, 2024 Ethiqa XR, an extended-release buprenorphine, adds captive rodents and laboratory rabbits to label for… Read more: Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®
- Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q®Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) — Kaléo, a privately-held U.S. pharmaceutical company has announced… Read more: Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q®